These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29847836)

  • 1. The effect of methylphenidate on decision making in patients with borderline personality disorder and attention-deficit/hyperactivity disorder.
    Gvirts HZ; Lewis YD; Dvora S; Feffer K; Nitzan U; Carmel Z; Levkovitz Y; Maoz H
    Int Clin Psychopharmacol; 2018 Jul; 33(4):233-237. PubMed ID: 29847836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P; Sever J; Zalsman G; Weizman A
    Int Clin Psychopharmacol; 2008 Jul; 23(4):228-31. PubMed ID: 18446088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study.
    Prada P; Nicastro R; Zimmermann J; Hasler R; Aubry JM; Perroud N
    Atten Defic Hyperact Disord; 2015 Sep; 7(3):199-209. PubMed ID: 25634471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD).
    DeVito EE; Blackwell AD; Clark L; Kent L; Dezsery AM; Turner DC; Aitken MR; Sahakian BJ
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):531-9. PubMed ID: 18818905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.
    Horowitz I; Avirame K; Naim-Feil J; Rubinson M; Moses E; Gothelf D; Levit-Binnun N
    Psychiatry Res; 2020 Sep; 291():113056. PubMed ID: 32554183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disorders.
    Golubchik P; Sever J; Weizman A
    Clin Neuropharmacol; 2009; 32(5):239-42. PubMed ID: 19834989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
    Idema IME; Payne JM; Coghill D
    J Consult Clin Psychol; 2021 Jul; 89(7):615-625. PubMed ID: 34383534
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder.
    Grizenko N; Cai E; Jolicoeur C; Ter-Stepanian M; Joober R
    Can J Psychiatry; 2013 Nov; 58(11):632-9. PubMed ID: 24246434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Greenhill LL; Nordbrock E; Connor DF; Kollins SH; Adjei A; Childress A; Stehli A; Kupper RJ
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):562-9. PubMed ID: 25470572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of methylphenidate on the cognitive and personality functioning of ADHD children.
    Lufi D; Parish-Plass J; Gai E
    Isr J Psychiatry Relat Sci; 1997; 34(3):200-9. PubMed ID: 9334525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder.
    DeVito EE; Blackwell AD; Kent L; Ersche KD; Clark L; Salmond CH; Dezsery AM; Sahakian BJ
    Biol Psychiatry; 2008 Oct; 64(7):636-9. PubMed ID: 18504036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
    Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
    Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: a 13-week, randomized, double-blind, placebo-controlled, fixed-dose study.
    Casas M; Rösler M; Sandra Kooij JJ; Ginsberg Y; Ramos-Quiroga JA; Heger S; Berwaerts J; Dejonckheere J; van der Vorst E; Schäuble B
    World J Biol Psychiatry; 2013 May; 14(4):268-81. PubMed ID: 22106853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial.
    Ishii-Takahashi A; Takizawa R; Nishimura Y; Kawakubo Y; Hamada K; Okuhata S; Kawasaki S; Kuwabara H; Shimada T; Todokoro A; Igarashi T; Watanabe K; Yamasue H; Kato N; Kasai K; Kano Y
    Neuropsychopharmacology; 2015 Nov; 40(12):2676-85. PubMed ID: 25936640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition.
    Hawk LW; Fosco WD; Colder CR; Waxmonsky JG; Pelham WE; Rosch KS
    J Child Psychol Psychiatry; 2018 Dec; 59(12):1271-1281. PubMed ID: 29733106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.